Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Revenue

Cidara Therapeutics had revenue of $44.65M in the twelve months ending September 30, 2024, up 44.48% year-over-year. In the year 2023, Cidara Therapeutics had annual revenue of $63.91M, down -0.84%.

• Revenue (ttm): $44.65M
• Revenue Growth: +44.48%
• P/S Ratio: 1.71
• Revenue / Employee: $647,145
• Employees: 69
• Market Cap: 106.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	63.91M	-543.00K	-0.84%
Dec 31, 2022	64.45M	14.88M	30.01%
Dec 31, 2021	49.57M	37.51M	310.81%
Dec 31, 2020	12.07M	-8.85M	-42.30%
Dec 31, 2019	20.92M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.